ACT Enact Holdings, Inc.
Enact Holdings, Inc. operates as a private mortgage insurance company in the United States. The company engages in writing and assuming residential mortgage guaranty insurance. It also offers private mortgage insurance products insuring prime-based, individually underwritten residential mortgage loans; pool mortgage insurance; contract underwriting services; and mortgage-related reinsurance products. The company serves large money center banks, non-bank lenders, national and local mortgage bankers, community banks, and credit unions. The company was formerly known as Genworth Mortgage Holdings, Inc. and changed its name to Enact Holdings, Inc. in May 2021. Enact Holdings, Inc. was founded in 1981 and is headquartered in Raleigh, North Carolina. Enact Holdings, Inc. is a subsidiary of Genworth Holdings Inc.…
Industry Peers
Insurance - SpecialtyKey Statistics
About Enact Holdings (NASDAQ: ACT)
›
Enact Holdings (NASDAQ: ACT) is listed on Nasdaq, where its shares trade in USD. It belongs to the Insurance - Specialty industry, part of the Financial Services sector, and reports about 419 employees.
The shares were at 44.19 USD on 19 November 2026, up 26.1% over 52 weeks. Its 52-week range is 34.64 USD to 50.47 USD: the price is 12.5% below the high and 27.6% above the low.
At a market capitalisation of 5.94B USD, it trades at 9.2 times trailing earnings and 8.8 times forward earnings. The median trailing P/E of its 17 largest Insurance - Specialty peers is 9.0, so ACT is valued in line with them. It pays a dividend yielding 2.13% (it pays out 19% of its earnings), against a median of 2.84% among the dividend payers in that peer group.
Enact Holdings reports return on equity of 12.6%, an operating margin of 72.5% and flat revenue year over year.
Its debt exceeds its cash by 195.91M USD, a debt-to-equity ratio of 0.14. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Hold; their mean price target of 47.00 USD is 6.4% above the current price. The next earnings report is expected on 9 February 2027.